These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2904849)

  • 1. [New views on the role of ascorbic acid in the central nervous system].
    Miele M; Desole MS; Demontis P; Bozzo C
    Clin Ter; 1988 Apr; 125(1):3-14. PubMed ID: 2904849
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of chronic treatment with central stimulants on brain monoamines and some behavioral and physiological functions in rats, guinea pigs, and rabbits.
    Lewander T
    Adv Biochem Psychopharmacol; 1974; 12(0):221-39. PubMed ID: 4607740
    [No Abstract]   [Full Text] [Related]  

  • 3. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
    Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
    Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of aziprine on the central nervous system].
    Ponomareva AG
    Farmakol Toksikol; 1969; 32(4):403-6. PubMed ID: 5357457
    [No Abstract]   [Full Text] [Related]  

  • 5. [Activity of Tephrosia vogelii, ichthyotoxic Papillonaceae from Madagascars on the central nervous system].
    Lefournier C; Ratsimamanga S; Chalopin H; Loiseau A; Rajoharison S
    C R Seances Acad Sci D; 1980 Jan; 290(3):219-22. PubMed ID: 6768461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
    Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
    Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of the central nervous system.
    Nelson SR; Walaszek EJ
    Prog Neurol Psychiatry; 1968; 23():134-54. PubMed ID: 4304825
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacology of the new antihistaminic 9,9-dioxopromethazine (Prothanon)].
    Bartsch R; Nowak R; Femmer K; Stade K
    Pharmazie; 1970 Feb; 25(2):91-6. PubMed ID: 4393060
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the pharmacology of the thymoleptic noxiptilin (Bay 1521)].
    Hoffmeister F; Wuttke W; Kroneberg G
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:846+. PubMed ID: 5819764
    [No Abstract]   [Full Text] [Related]  

  • 11. [Histamine and brain].
    Boissier JR
    Actual Pharmacol (Paris); 1971; 24():51-92. PubMed ID: 5150622
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacology of new tropine ethers with central activity.
    György L; Pfeifer AK; Dóda M; Galambos E; Molnár J; Kraiss G; Nádor K
    Arzneimittelforschung; 1968 May; 18(5):517-24. PubMed ID: 4387833
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methodical problems of psychopharmacology presented using the example of antidepressive agents].
    Hoffmeister F
    Arzneimittelforschung; 1969 May; 19(5):808-10. PubMed ID: 5819796
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and pharmacological investigations of new 6-oxo-1,2,3,4-tetrahydro-6H-pyrimido[2,1-b]quinazoline derivatives.
    Korzycka L; Szadowska A; Pakulska W
    Pharmazie; 1994 Nov; 49(11):815-9. PubMed ID: 7838867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
    Janssen PA; Niemegeers CJ; Schellekens KH; Dresse A; Lenaerts FM; Pinchard A; Schaper WK; van Nueten JM; Verbruggen FJ
    Arzneimittelforschung; 1968 Mar; 18(3):261-79. PubMed ID: 4386815
    [No Abstract]   [Full Text] [Related]  

  • 16. Time-related interaction patterns of amphetamine with reserpine and other central depressants.
    Banerjee U; Geh SL
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):109-22. PubMed ID: 4739077
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biochemical and pharmacological study of 3-(2-morpholino-ethylamino) 4-methyl 6-phenyl pyridazine dihydrochloride (Agar 1240)].
    Laborit H; Brunaud M; Savy JM; Baron C; Vallée E; Lamothe C; Thuret F; Muyard JP; Calvino B
    Agressologie; 1972; 13(5):291-317. PubMed ID: 4653534
    [No Abstract]   [Full Text] [Related]  

  • 18. Vitamin C and weight reducing drugs on brain ascorbic acid in guinea pigs.
    Odumosu A
    Acta Vitaminol Enzymol; 1981; 3(2):96-102. PubMed ID: 7325103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT.
    Shankaran M; Yamamoto BK; Gudelsky GA
    Synapse; 2001 Apr; 40(1):55-64. PubMed ID: 11170222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylcholine and amino acid neurotransmitters in epidural cups of freely moving rats: effect of acute and chronic treatment with antischizophrenic drugs.
    Moroni F; Casamenti F; Caliari S; Pisani G; Moneti G; Pepeu G
    Adv Biochem Psychopharmacol; 1980; 24():245-52. PubMed ID: 6105779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.